TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06746415

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Gait Training
Description: onventional walking training group will be given 20 minutes of NMES, 20 minutes of weight transfer, stretching, mobilization, bobath exercises and 20 minutes of parallel bar walking exercises. Patients in both groups will be treated 3 days a week, 1 hour a day for 6 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robotic Gait Training
Description: The robot-assisted walking group will receive 20 minutes of NMES, 20 minutes of weight transfer, stretching,mobilization, bobath exercises and 20 minutes of robot-assisted walking exercises. Patients in both groups will be treated 3 days a week, 1 hour a day for 6 weeks
Study: NCT04785066

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Administration of dornase alfa
Description: Patient treated for a cerebral thrombectomy will be administred dornase alfa treatment by intravenous
Study: NCT06631209

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: Specifically, Continual Theta Burst Stimulation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: Specifically, Continual Theta Burst Stimulation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: Specifically, Continual Theta Burst Stimulation
Study: NCT05642988

Intervention type: DEVICE
Intervention: LifeSignals 1AX Biosensor
Description: Biosensor worn by patients for 30-days after intra-abdominal or pelvic surgery on discharge from hospital
Study: NCT05132634

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand Massage
Description: Like a massage, the superficial kneading technique which is included in the Swedish massage technique will be applied in a way to create a slight pressure on the patient, and it will be terminated again with the effleurage technique. The procedure was concluded in a way that each massage technique was applied and the massage was for a total of 15-20 minutes.
Study: NCT06631209

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Sham TMS
Study: NCT04740359

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional training
Description: The therapy program was planned for 8 weeks and the sessions were performed in 45 minutes (min) for 3 days a week. The functional reach (forward-lateral-cross), trunk rotation exercises were performed in the sitting positions.(25min) Facilitation of trunk extension and elongation in the prone position (10 min). Thoracic mobilization on exercise ball (10min).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine training
Description: The therapy program was planned for 8 weeks and the sessions were performed in 45 minutes (min) for 3 days a week. The strengthening exercises were applied on the mat (3x10 for the first 4 weeks and 3x15 repetition for the last 4 weeks). Eyes open-closed perturbation training was performed for trunk control in sitting and standing positions (10 min.).
Study: NCT05406362

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VAD044
Description: capsules to be taken once daily for 12 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VAD044
Description: capsules to be taken once daily for 12 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: VAD044
Description: capsules to be taken once daily for 12 weeks
Study: NCT06220058

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Closure of the midline laparotomy using the small bites technique
Description: Closure of the midline laparotomy using the small bites technique will involve employing a monofilament polydioxanone suture with a gauge of 0 (PDS® II Ethicon, Bridgewater, NJ). No Redon drainage system will be left in the subcutaneous tissue.
Study: NCT05649566

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality game
Description: The game consists of cutting mobile targets, using lightsabers while avoiding obstacles that approach the user. This game is a reference for immersive play since, while distracting, it recreates a physical activity similar to what would be done in reality. It has been shown that the same energy expenditure, on the part of the user, practicing tennis in real life, is what he does playing Beat Saber playing the same period of time.
Study: NCT06220058

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Closure of the midline laparotomy using the small bites technique with an absorbable PP mesh
Description: Closure of the midline laparotomy using the small bites technique will involve employing a monofilament polydioxanone suture with a gauge of 0 (PDS® II Ethicon, Bridgewater, NJ). A partially absorbable low-density polypropylene suprapubic mesh (Ultrapro®, Ethicon) will be added. Mesh fixation will be done with absorbable staples (Ethicon SecurestrapTM) +/- slow-absorbing resorbable sutures at the discretion of the surgical team.~In the case of a diverting stoma, the prophylactic mesh will not encircle it. A Redon-type drainage will be left at the subcutaneous tissue level. One or two drains will be left at the discretion of the surgical team. Closure of the subcutaneous tissue will be performed with 2/0 or 3/0 absorbable, multifilament, interlocking sutures.
Study: NCT04853030

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fiasp
Description: Advanced closed-loop insulin therapy with Faster acting insulin Aspart (Fiasp)
Study: NCT05091593

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stepped collaborative care intervention
Description: Using website that was specifically designed for advanced cancer patient, collaborative with treatment from health professional.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Usual care from health providers
Study: NCT06746792

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-load resistance exercise with blood flow restriction
Description: BFR-RE group performed bilateral leg extension exercises to volitional exhaustion (90 seconds rest between sets, 30% 1RM) with BFR cuffs applied at 60% of limb occlusion pressure.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-load resistance exercise with blood flow restriction
Description: BFR-RE group performed bilateral leg extension exercises to volitional exhaustion (90 seconds rest between sets, 30% 1RM) with BFR cuffs applied at 60% of limb occlusion pressure.
Study: NCT04853030

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Novorapid
Description: Advanced closed-loop insulin therapy with Standard acting insulin Aspart (Novorapid
Study: NCT06203093

Intervention type: OTHER
Intervention: Biological Sample Collection
Description: Skin biopsy (2-3mm) and/or blood (up to 50mL); saliva; excess/leftover biospecimens that were (or will be) collected for other purposes (e.g., medical procedure).
Study: NCT06344247

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dapagliflozin：Forxiga®️
Description: Forxiga®️ : titrated to the target dose (10 mg qd).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simagliptin：Forxiga®️
Description: Semaglutide®️ : titrated to the target dose (1 mg qw).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simagliptin：Forxiga®️
Description: Semaglutide®️ : titrated to the target dose (1 mg qw).
Study: NCT04132297

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Asthma Academy
Description: The Asthma Academy is a one hour virtual training that includes providing information about asthma, asthma medications, communicating with healthcare providers and navigating healthcare resources.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Asthma Academy
Description: The Asthma Academy is a one hour virtual training that includes providing information about asthma, asthma medications, communicating with healthcare providers and navigating healthcare resources.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Visit
Description: The telehealth Visit will be conduct by a trained Doctor of Nurse Practice (DNP) student via a scheduled meeting through zoom on the participant's smart phone or computer. The visit will last about one hour wherein participant will be asked about their asthma knowledge and will be given information about asthma.
Study: NCT06158152

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: AM3 + Probiotic
Description: Two capsules daily in the morning during 12 weeks. The capsule contains the mixture of AM3 Technology and probiotic SynBalance Metsyn.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two capsules daily in the morning during 12 weeks. The capsule contains starch.

Intervention type: DIETARY_SUPPLEMENT
Group type: SHAM_COMPARATOR
Intervention: AM3
Description: Two capsules daily in the morning during 12 weeks. The capsule contains AM3 Technology.
Study: NCT05401916

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: Patients will be received tramadol with intravenous patient controlled analgesia (IV PCA) device during postoperative 24 hours. The PCA solution will be prepared with 500 mg tramadol in 100 mL of saline (5 mg/ml). The PCA device was adjusted as infusion: 2 ml/h, bolus: 2 ml, lockout period: 15 min.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: Patients will be received tramadol with intravenous patient controlled analgesia (IV PCA) device during postoperative 24 hours. The PCA solution will be prepared with 500 mg tramadol in 100 mL of saline (5 mg/ml). The PCA device was adjusted as infusion: 2 ml/h, bolus: 2 ml, lockout period: 15 min.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paracetamol
Description: 1 g paracetamol will be administered 30 minutes before the end of surgery. All administrations will be applied through IV infusion over 30 minutes. Patients will be received tramadol with intravenous patient controlled analgesia (IV PCA) device during postoperative 24 hours. The PCA solution will be prepared with 500 mg tramadol in 100 mL of saline (5 mg/ml). The PCA device was adjusted as infusion: 2 ml/h, bolus: 2 ml, lockout period: 15 min.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: 800 mg ibuprofen (diluted with 250 ml saline) will be administered 30 minutes before the end of surgery. All administrations will be applied through IV infusion over 30 minutes. Patients will be received tramadol with intravenous patient controlled analgesia (IV PCA) device during postoperative 24 hours. The PCA solution will be prepared with 500 mg tramadol in 100 mL of saline (5 mg/ml). The PCA device was adjusted as infusion: 2 ml/h, bolus: 2 ml, lockout period: 15 min.
Study: NCT06746792

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-load resistance exercise
Description: The HL-RE group performed the same exercise to volitional exhaustion (90 seconds rest between sets, 70% 1RM) without BFR cuffs.
Study: NCT06402305

Intervention type: DIAGNOSTIC_TEST
Intervention: Lipid profile
Description: Abdominal ultrasound and lipid profile will be done

Intervention type: DIAGNOSTIC_TEST
Intervention: Lipid profile
Description: Abdominal ultrasound and lipid profile will be done
Study: NCT06745960

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: electrical muscle stimulation device (EMS gymna)
Description: muscle stimulant device

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: physical therapy program
Description: neck exercises

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: physical therapy program
Description: neck exercises
Study: NCT06747559

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Vitamin D oral supplementation
Study: NCT06746805

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: CHO+KETONE
Description: Sports drink containing glucose and ketone mono-esters

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: CHO+PLACEBO
Description: Sports drink containing glucose and placebo
Study: NCT06747429

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High fat diet
Description: Weekly isocaloric dietary profile, with total daily energy intake distributed as follows: 70% from fats, primarily sourced from nuts, extra virgin olive oil, avocados, and animal fats from fish and cheese; protein intake of 0.8-1.2 g per kg body weight (10-20%); and the remaining calories from carbohydrates (10-20%).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard diet
Description: Weekly isocaloric dietary profile, with total daily energy intake distributed as follows: 30% from fats, primarily sourced from nuts, extra virgin olive oil, avocados, and animal fats from fish and cheese; protein intake of 0.8-1.2 g per kg body weight (10-20%); and 50-60% from carbohydrates.
Study: NCT06548334

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Advanced Physiotherapy
Description: The physiotherapist used the regression techniques for 1 hour of session 2 times for 8 weeks. The caudal component involved the spinous process of the treated segment touching the therapist's hand and not applying force as though mobilising the segment at grade 2. These were applied if there is a suspected case of a posterolateral disc prolapse where the aim is to increase the diameter of the foramen and decrease the tension exerted on the nerve root. Applied posteroanterior was used to distract the anterior intervertebral end plate and to approximate the posterior end plates so as to pull back the protruded nuclear material by creating a negative pressure.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy Techniques
Description: In traditional physiotherapy, the patient underwent two sessions per week for eight weeks. Each session lasted one hour and included 20minutes of TENS treatment. The flexibility exercises consisted of hamstring stretches and single and double knee-to-chest stretches. The strengthening exercises were partial sit-ups, quadruped lifts, and double leg hold; pelvic tilts were performed with 10-15 repetitions, each held for 20-30 seconds and repeated three times.
Study: NCT06746558

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Potassium Nitrate Gel and Diode Laser Therapy
Description: Participants in the experimental group receive treatment combining a desensitizing gel containing 5% potassium nitrate (Emoform Actisens) applied to affected teeth and diode laser therapy (980 nm). The laser is used with specific power settings (0.3W, 0.5W, 0.7W) for 20 seconds at each setting, followed by a second application of the gel and irradiation. The treatment aims to reduce dentinal hypersensitivity by occluding dentinal tubules and altering neural responses.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Potassium Nitrate Gel Alone
Description: Participants in the control group receive treatment with a desensitizing gel containing 5% potassium nitrate (Emoform Actisens) applied to the teeth. The gel is applied twice using a microbrush in a rubbing motion for 2 minutes each time. No diode laser therapy is administered. This intervention aims to evaluate the standalone efficacy of the gel in reducing dentinal hypersensitivity.
Study: NCT06249633

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitric Oxide
Description: Inhaled nitric oxide
Study: NCT06747845

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niraparib
Description: Niraparib 200mg PO daily on days 1-21 of each 21-day cycle.

Intervention type: DRUG
Group type: OTHER
Intervention: FOLFIRI
Description: Standard chemotherapy FOLFIRI (5-fluorouracil, folinic acid, and irinotecan) will be administered intravenously every 14 days of a 28-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Ipilimumab 3mg/kg IV day 1 of each cycle, for the first 4 cycles only.
Study: NCT05781360

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0237
Description: SIM0237 should be administered intravenously at recommended dose qw or other dosing regimens

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0237
Description: SIM0237 should be administered intravenously at recommended dose qw or other dosing regimens
Study: NCT05497778

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Given by IV (vein)
Study: NCT05461924

Intervention type: OTHER
Intervention: questionnaire survey
Description: questionnaire survey the long term outcomes of long-segment HSCR and compared with rectosigmoid HSCR

Intervention type: OTHER
Intervention: questionnaire survey
Description: questionnaire survey the long term outcomes of long-segment HSCR and compared with rectosigmoid HSCR
Study: NCT05497778

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: Given by IV (vein)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IM156
Description: Given by PO
Study: NCT06477419

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan-hziy
Description: After enrollment, participants will receive SG until disease progression or intolerable toxicity.
Study: NCT05395351

Intervention type: DRUG
Intervention: rt-PA
Description: Intravenous recombinant tissue plasminogen activator (IV rt-PA)

Intervention type: DRUG
Intervention: rt-PA
Description: Intravenous recombinant tissue plasminogen activator (IV rt-PA)
Study: NCT05065437

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active (Virtual reality and spinal stimulation)
Description: Each session is 25 minutes; 5 minutes of setup, and 20 minutes of simultaneous spinal stimulation at the cervical level and immersive virtual experience/gameplay.
Study: NCT05663372

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efez 50 mg eplerenone film-coated tablets
Description: Oral, mineralocorticoid receptor antagonist, a blocker of aldosterone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: INSPRA® 50 mg eplerenone film-coated tablets
Description: Oral, mineralocorticoid receptor antagonist, a blocker of aldosterone
Study: NCT05799716

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IVIG
Description: 0.5g/Kg
Study: NCT04823819

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Magnetic Stimulator DuoMag
Description: Stimulation of the left dorsolateral prefrontal cortex

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Stimulator DuoMag
Description: Stimulation of the left dorsolateral prefrontal cortex

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: neuroConn DC-STIMULATOR
Description: One electrode (anode) will be placed on the left dorsolateral prefrontal cortex, the other (cathode) on the right temporal lobe.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: neuroConn DC-STIMULATOR
Description: One electrode (anode) will be placed on the left dorsolateral prefrontal cortex, the other (cathode) on the right temporal lobe.
Study: NCT05234216

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informed consent
Description: the investigator will verify the inclusion criteria, the patient's understanding of the protocol and will obtain oral informed consent

Intervention type: OTHER
Group type: OTHER
Intervention: Informed consent
Description: the investigator will verify the inclusion criteria, the patient's understanding of the protocol and will obtain oral informed consent

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: The patient will undergo surgery in accordance with standard care

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgery
Description: The patient will undergo surgery in accordance with standard care

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comfort scale
Description: The patient will be evaluated, in the post-operative care unit, with a comfort scale

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pain
Description: The patient will be evaluated, in the post-operative care unit, with a pain scale

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Evaluation of the Experience of Local/General Anesthesia

Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaires
Description: Evaluation of the Experience of Local/General Anesthesia
Study: NCT05299580

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dabrafenib
Description: Dabrafenib 150 mg bid

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Trametinib 2mg qd
Study: NCT04835259

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Selenium Amino Acid Chelate (Selenium ACE cream)
Description: application of a topical agent over the whole face for 6 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Selenium Amino Acid Chelate (Selenium ACE cream)
Description: application of a topical agent over the whole face for 6 months

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Selenium Amino Acid Chelate (Selenium ACE cream)
Description: application of a topical agent over the whole face for 6 months
Study: NCT06057090

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapy Dog
Description: Certified, volunteer therapy dogs and their handlers will be present in the room during procedures in the experimental arm to see if their presence reduces anxiety and improves behavior in pediatric dental patients.
Study: NCT04512690

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Epidural electrical stimulation (EES) of the cervical spinal cord
Description: All participants enrolled in this group will undergo a surgical procedure to implant a system which provides epidural electrical stimulation (EES) of the cervical spinal cord. Researchers will quantify the ability of EES to recruit arm and hand muscles and produce distinct kinematic movements. The implant will be removed after less than 30 days.
Study: NCT05114174

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mami-educ
Description: The intervention corresponds to sending 3 messages a week through Telegram, with nutritional information, for 12 consecutive weeks (a different nutritional topic each week). The messages address the three domains of learning, cognitive, affective, and psychomotor for each topic.
Study: NCT05409794

Intervention type: BIOLOGICAL
Intervention: Blood sample
Description: Blood sample for the determination of plasma lithium levels

Intervention type: BIOLOGICAL
Intervention: Blood sample
Description: Blood sample for the determination of plasma lithium levels
Study: NCT04992273

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casirivimab+imdevimab
Description: Single dose administered based on weight

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casirivimab+imdevimab
Description: Single dose administered based on weight

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casirivimab+imdevimab
Description: Single dose administered based on weight

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casirivimab+imdevimab
Description: Single dose administered based on weight